|Articles|October 10, 2018

PAREXEL Announces New Patient-Centric Innovations to Address Drug Development Challenges

PAREXEL International Corporation, a provider of global biopharmaceutical services, announced that it has developed new solutions that take a patient-centric approach to addressing drug development. These solutions were built on the Perceptive Cloud platform in hopes to leverage mobile and wearable technology.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related to this article

October 19th, 2026

How Compressing Time From Data Capture to Insight Changes Trial Risk Management

In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, explains why the real advantage of faster data isn’t speed—it’s shortening the distance between signals, human judgment, and the next best action.

October 19th, 2026

ACT Brief: AI Operating Models, Oncology Evidence Trust, and Thyroid Eye Disease Approval

In today’s ACT Brief, we examine how AI is moving into continuous clinical operating models, how trust is built into oncology real-world evidence, and how the FDA approved a self-administered option for thyroid eye disease.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: Should the Industry Rethink What Scale Means?

Paradigm’s Kurt Mussina discusses why scale should drive operational efficiency, not consolidation into single-site studies.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: The Difference Between Owning a Group of Sites and Operating Them as One Integrated Platform

Paradigm’s Kurt Mussina touches on why he rejects the “site management organization” model in favor of one unified business.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What's a Mistake Sponsors or CROs Make When Rolling Out New Trial Technology?

ProofPilot’s Lauren Briggs talks on why sponsors and CROs fail at tech rollouts by skipping change management, and pushes for the industry to judge trial technology by real workflow impact rather than feature checklists.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What Causes Technology Adoption to Stall?

ProofPilot’s Lauren Briggs touches on why site tech adoption hinges on the first 90 days after rollout, and why tools succeed only when they remove work from a site’s plate rather than adding another login to juggle.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What's the Biggest Policy Gap Delaying Integrated, Community-Based Research Being the Norm?

Jennifer Byrne, CEO, Javara touches on why fixing clinical research requires sustained infrastructure investment and workforce development.

Dan White, CEO, and Dr. Tom Kreamer, CMO

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What Should Sponsors and CROs Change About How They Contract with a Network?

Sequoia’s Dan White and Dr. Tom Kreamer touch on why sponsors and CROs should treat a site network as one centralized partnerto speed startup timelines and strengthen execution.

PAREXEL Announces New Patient-Centric Innovations to Address Drug Development Challenges

Related to this article

Trending on Applied Clinical Trials Online

2026 SCRS Global Site Solutions Summit: What Should Sponsors and CROs Change About How They Contract with a Network?

2026 SCRS Global Site Solutions Summit: What's the Biggest Policy Gap Delaying Integrated, Community-Based Research Being the Norm?

2026 SCRS Global Site Solutions Summit: What's a Mistake Sponsors or CROs Make When Rolling Out New Trial Technology?

What It Actually Means to Embed AI Across the Clinical Operating Model

2026 SCRS Global Site Solutions Summit: Should the Industry Rethink What Scale Means?